Rigel Pharma is a profitable biotech with three FDA-approved drugs, experiencing accelerating revenue growth led by Tavalisse's strong performance. RIGL trades at a significant discount to biotech ...

SOUTH SAN FRANCISCO, Calif., Nov. 26, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today ...

Rigel Pharmaceuticals, Inc. shares have moved up sharply after posting Q3 results, driven by robust top-line growth across all products. RIGL's commercial assets—Tavalisse, Rezlidhia, and ...

Have you been paying attention to shares of Rigel Pharmaceuticals (RIGL)? Shares have been on the move with the stock up 73.3% over the past month. The stock hit a new 52-week high of $51.73 in the ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

NASHVILLE – In a festive conference room, the sounds of "Silent Night" spill into the air. Surrounded by twinkling lights and half-empty coffee cups, the three members of Lady A – Hillary Scott, ...

In the daytime, they're just normal people, living a normal life... but there's something about them that no one knows yet... they're superheroes! Ladybug and Cat Noir conquer challenges, enemies and ...

In the daytime, they're just normal people, living a normal life... but there's something about them that no one knows yet... they're superheroes! Ladybug and Cat Noir conquer challenges, enemies and ...

Bed bug bites often appear in zig-zag lines or clusters of three or more bites, and may take up to 14 days to appear. Scratching them can lead to secondary skin infections, which may require ...

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology.